Error in Figure and Omission of Clinical Trial Registration Number in: Ranibizumab Combined With Verteporfin Photodynamic Therapy in Neovascular Age-Related Macular Degeneration

Trial Registration ◽

Clinical Trial Registration ◽

Age Related ◽

Registration Number

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2

American Journal of Ophthalmology ◽

10.1016/s0002-9394(01)00967-9 ◽

2001 ◽

Vol 131 (5) ◽

pp. 541-560 ◽

Cited By ~ 617

Keyword(s):

Clinical Trial ◽

Photodynamic Therapy ◽

Macular Degeneration ◽

Choroidal Neovascularization ◽

Subfoveal Choroidal Neovascularization

Verteporfin Therapy ◽

Age Related ◽

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2

American Journal of Ophthalmology ◽

10.1016/s0002-9394(01)01237-5 ◽

2002 ◽

Vol 133 (1) ◽

pp. 168-169 ◽

Cited By ~ 41

Author(s):

Neil M. Bressler

Keyword(s):

Clinical Trial ◽

Photodynamic Therapy ◽

Macular Degeneration ◽

Choroidal Neovascularization ◽

Subfoveal Choroidal Neovascularization

Verteporfin Therapy ◽

Age Related ◽

Photodynamic therapy and intravitreal bevacizumab with versus without triamcinolone for neovascular age-related macular degeneration; a randomized clinical trial

Journal of Ophthalmic and Vision Research ◽

10.4103/2008-322x.150826 ◽

2014 ◽

Vol 9 (4) ◽

pp. 469 ◽

Cited By ~ 1

Author(s):

Mohammad Riazi Esfahani ◽

Hamid Ahmadieh ◽

Faegheh Golbafian ◽

Niloofar Piri ◽

Ramin Taei ◽

...

Keyword(s):

Clinical Trial ◽

Photodynamic Therapy ◽

Macular Degeneration ◽

Intravitreal Bevacizumab ◽

Subretinal Hemorrhage After Photodynamic Therapy for Age-Related Macular Degeneration

Journal of the Korean Ophthalmological Society ◽

10.3341/jkos.2008.49.10.1603 ◽

2008 ◽

Vol 49 (10) ◽

pp. 1603

Author(s):

Jae Moon Yoon ◽

Ho Soong Kim ◽

Jae Hoon Kang ◽

Hee Sung Yoon

Keyword(s):

Photodynamic Therapy ◽

Macular Degeneration ◽

Subretinal Hemorrhage ◽

Faculty of 1000 evaluation for Improving function in age-related macular degeneration: a randomized clinical trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718007696.793478654 ◽

2013 ◽

Author(s):

David Boyer

Keyword(s):

Clinical Trial ◽

Macular Degeneration ◽

Faculty Opinions recommendation of Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718007638.793493580 ◽

2014 ◽

Author(s):

Michael Singer

Keyword(s):

Clinical Trial ◽

Fatty Acids ◽

Macular Degeneration ◽

Eye Disease ◽

Omega 3 Fatty Acids ◽

Omega 3 ◽

Age Related ◽

Disease Study

Faculty Opinions recommendation of Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718007638.793477261 ◽

2013 ◽

Author(s):

Karl Csaky ◽

Debbie Chong

Keyword(s):

Clinical Trial ◽

Fatty Acids ◽

Macular Degeneration ◽

Eye Disease ◽

Omega 3 Fatty Acids ◽

Omega 3 ◽

Age Related ◽

Disease Study

A Traditional Chinese Patent Medicine ZQMT for Neovascular Age- Related Macular Degeneration: A Multicenter Randomized Clinical Trial

Current Molecular Medicine ◽

10.2174/1566524019666190107155311 ◽

2019 ◽

Vol 18 (9) ◽

pp. 622-629 ◽

Cited By ~ 2

Author(s):

M. Jin ◽

H. Dai ◽

X. Zhang ◽

Y. Wang ◽

M. Han ◽

...

Keyword(s):

Clinical Trial ◽

Macular Degeneration ◽

Chinese Patent Medicine ◽

Age Related ◽

Chinese Patent ◽

Traditional Chinese Patent Medicine ◽

Patent Medicine

Treatment of age-related macular degeneration with laser photocoagulation and photodynamic therapy

Current Issues in Age-Related Macular Degeneration ◽

10.2217/fmeb2013.13.171 ◽

2014 ◽

pp. 124-142

Author(s):

Michael W Stewart

Keyword(s):

Photodynamic Therapy ◽

Macular Degeneration ◽

Laser Photocoagulation ◽

Re: Campochiaro et al.: The Port Delivery System with ranibizumab for neovascular age-related macular degeneration: results from the randomized phase 2 Ladder clinical trial (Ophthalmology. 2019;126:1141-1154)

Ophthalmology ◽

10.1016/j.ophtha.2019.06.019 ◽

2019 ◽

Vol 126 (11) ◽

pp. e87-e88 ◽

Cited By ~ 1

Author(s):

Ashish Sharma ◽

Nilesh Kumar ◽

Baruch D. Kuppermann ◽

Bandello Francesco

Keyword(s):

Clinical Trial ◽

Macular Degeneration ◽

Delivery System ◽

Phase 2 ◽

Age Related ◽

Randomized Phase 2